Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

No longer available × Neuroendocrine Tumors × Ga(III)-DOTATOC × Clear all

Status

No longer available 2 Completed 2 Terminated 1

Sponsor Class

Study Type

Expanded_access 2

Sponsor

Cancer Type

NET 2 Endocrine 2

Conditions

Neuroendocrine Tumors 2 Carcinoma, Medullary 1 Carcinoid Tumor 1

Interventions

Ga(III)-DOTATOC 2 surufatinib 1 Gallium-68 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02174679 2020-07-27

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Jonsson Comprehensive Cancer Center

No longer available

Carcinoma, Medullary, Neuroendocrine Tumors

NCT02375464 2016-11-08

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

Northwell Health

No longer available

Carcinoid Tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡